New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

Human Reproduction

Volumn 19, Issue 3, 2004, Pages 486-489

  Delbaere, A ^a   Smits, G ^a,b   Olatunbosun, O ^c   Pierson, R ^c   Vassart, G ^a,b   Costagliola, S ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

FSH receptor; OHSS; Physiopathology

Indexed keywords

ADENINE; ASPARAGINE; ASPARTIC ACID; CHORIONIC GONADOTROPIN; CYTOSINE; FOLLITROPIN; FOLLITROPIN RECEPTOR; GUANINE; THYMIDINE;

AMINO ACID SUBSTITUTION; ARTICLE; CHRONOLOGY; DISEASE MODEL; FEMALE; GENE MUTATION; HORMONE SENSITIVITY; HUMAN; IATROGENIC DISEASE; LUTEINIZATION; MOLECULAR MECHANICS; OVARY DISEASE; OVARY FOLLICLE MATURATION; PATHOPHYSIOLOGY; SYMPTOM;

EID: 1542607370     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh124     Document Type: Article

References (30)

1. Aboulghar M (2003) Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod 18,1140-1141.
2. Aboulghar MA and Mansour RT (2003) Ovarian hyperstimulation syndrome: Classifications and critical analysis of preventive measures. Hum Reprod Update 9,275-289.
3. Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B and Barak V (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 11,1381-1386.
4. Check JH, Choe JK and Nazari A (2000) Hyperreactio luteinalis despite the absence of a corpus luteum and suppressed follicle stimulating concentrations in a triplet pregnancy. Hum Reprod 15,1043-1045.
5. Delbaere A, Bergmann PJM, Gervy-Decoster C, Staroukine M and Englert Y (1994) Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: Implications for pathophysiology and clinical management. Fertil Steril 62,731-737.
6. Delbaere A, Bergmann PJM, Gervy-Decoster C, Camus M, de Maertelaer V and Englert Y (1997a) Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum Reprod 12,236-240.
7. Delbaere A, Bergmann PJM, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M, Camus M and Englert Y (1997b) Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: Role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril 67,1038-1045.
8. Delvigne A and Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update 8,559-577.
9. 125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome. Hum Reprod 12,2115-2117.
10. DiZerega G and Hodgen G (1979) Pregnancy-associated ovarian refractoriness to gonadotropin: A myth. Am J Obstet Gynecol 134,819-822.
11. Elchalal U and Schenker JG (1997) The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. Hum Reprod 12,1129-1137.
12. Edi-Osagie ECO and Hopkins RE (1997) Recurrent idiopathic ovarian hyperstimulation syndrome in pregnancy. Br J Obstet Gynaecol 104,952-954.
13. Glinoer D (1997) The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18,404-433.
14. Hollemaert S, Wautrecht J-C, Capel P, Abramowicz MJ, Englert Y and Delbaere A (1996) Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation. Thromb Haemost 76,275-276.
15. Ludwig M, Gembruch U, Bauer O and Diedrich K (1998) Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: Information about the general pathophysiology of OHSS. Hum Reprod 13,2082-2087.
16. McClure N, Healy DL, Rogers PAW, Sullivan J, Beaton L, Haning Jr, RV, Connolly DT and Robertson DM (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344, 235-236.
17. Nappi RG, Di Nero E, D'Aries AP and Nappi L (1998) Natural pregnancy in hypothyroid woman complicated by spontaneous ovarian hyperstimulation syndrome. Am j Obstet Gynecol 178,610-611.
18. Navot D, Bergh PA and Laufer N (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril 58,249-261.
19. Olatunbosun OA, Gilliland B, Brydon LA, Chizen DR and Pierson RA (1996) Spontaneous ovarian hyperstimulation syndrome in four consecutive pregnancies. Clin Exp Obstet Gynecol 23,127-132.
20. Orvieto R (2003) Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos. Hum Reprod 18,665-667.
21. Rodien P, Bremont C, Sanson ML, Parma J, Van Sande J, Costagliola S, Luton JP, Vassart G and Duprez L (1998) Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339,1823-1826.
22. Schubert RL, Narayan P and Puett D (2003) Specificity of cognate ligand-receptor interactions: Fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroidstimulating hormone, and follicle-stimulating hormone. Endocrinology 144,129-137.
23. Simoni M, Gromoll J and Nieschlag E (1997) The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18,739-773.
24. Smits G, Olatunbosun OA, Delbaere A, Pierson RA, Vassart G and Costagliola S (2003a) Spontaneous ovarian hyperstimulation syndrome caused by a mutant follitropin receptor. N Engl J Med 349,760-766.
25. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L and Costagliola S (2003b) Glycoprotein hormone receptors: Determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22,2692-2703.
26. Tulchinsky D and Hobel CJ (1973) Plasma human chorionic gonadotropin, estrone, estradiol, progesterone, and 17α-hydroxyprogesterone in human pregnancy. Am J Obstet Gynecol 117,884-893.
27. Vasseur C, Rodien P, Beau I, Desroches A, Gérard C, de Poncheville L, Chaplot S, Savagner F, Croué A, Mathieu E et al (2003) A chorionic gonadotropin-sensitive mutation in the follicle-stimulationg hormone receptor as a cause of a familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349,753-759.
28. Vischer HF, Granneman JC, Noordam MJ, Mosselman S and Bogerd J (2003) Ligand selectivity of gonadotropin receptors. Role of the beta-strands of extracellular leucine-rich repeats 3 and 6 of the human luteinizing hormone receptor. J Biol Chem 278,15505-15513.
29. White CA and Bradbury JT (1965) Ovarian theca lutein cysts. Experimental formation in women prior to repeat cesarean section. Am J Obstet Gynecol 92,973-980.
30. Zalel Y, Orvieto R, Ben-Rafael Z, Homburg R, Fisher O and Insler V (1995) Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome. Gynecol Endocrinol 9,313-315.